EPAS1 induction drives myocardial degeneration in desmoplakin-cardiomyopathy

Eirini Kyriakopoulou1, Sebastiaan J van Kampen1, Martijn Wehrens1

  • 1Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Utrecht, the Netherlands.

Iscience
|March 4, 2025
PubMed

Insights

Pathogenic desmoplakin (DSP) variants cause arrhythmogenic cardiomyopathy (ACM) by disrupting mitochondrial function. Increased endothelial PAS domain-containing protein 1 (EPAS1) levels are linked to this degeneration, suggesting EPAS1 as a therapeutic target in DSP-cardiomyopathy.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Arrhythmogenic cardiomyopathy (ACM) is often caused by desmoplakin (DSP) gene mutations.
  • DSP-cardiomyopathy leads to myocardial degeneration and arrhythmias, but mechanisms are unclear.
  • Understanding these mechanisms is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying DSP-cardiomyopathy.
  • To identify key regulators of myocardial degeneration in DSP-cardiomyopathy.
  • To explore potential therapeutic targets for this condition.

Main Methods:

  • Spatial transcriptomics was performed on an explanted heart from a patient with a pathogenic DSP variant.
  • In vitro ACM models and additional explanted hearts were analyzed.
  • Transcriptional and mitochondrial function analyses were conducted.

Main Results:

  • Endothelial PAS domain-containing protein 1 (EPAS1) was identified as a potential regulator of mitochondrial homeostasis.
  • Elevated EPAS1 levels correlated with mitochondrial dysfunction and hypoxic stress in DSP-cardiomyopathy.
  • DSP-cardiomyopathy cardiomyocytes showed mitochondrial dysfunction, apoptosis, and impaired contractility linked to increased EPAS1.

Conclusions:

  • EPAS1 is implicated as a key regulator of myocardial degeneration in DSP-cardiomyopathy.
  • These findings may extend to other forms of arrhythmogenic cardiomyopathy.
  • EPAS1 represents a potential therapeutic target for DSP-cardiomyopathy and related conditions.

Related Concept Videos

Desmosomes01:05

Desmosomes

The term desmosome derives from the Greek words "desmo" and "soma" meaning "adhesion bodies." This structure was first observed during the late 1800s and described as small, dense nodules in the epidermis. Desmosomes are button-like structures that help form an interlinked network of intermediate filaments across the cells. These junctions are  essential to hold cells together under mechanical stress and to maintain tissue integrity. Desmosomes are multi-protein complexes comprising desmosomal...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...